TL;DR: Among Hispanic and Latino adults in the U.S., people with one particular DNA pattern around the APOE gene were more likely to show steep thinking decline over about 7 years. The well-known APOE4 risk version had a weaker link in the same group. Key Findings 3 DNA profiles: Short DNA sequences near APOE sorted …
FTL1 Iron Protein Reversed Old Mouse Memory Loss TL;DR: In old mice, an iron-associated hippocampal protein called FTL1 rose with cognitive decline, made young brains look older when boosted, and improved old-mouse cognition when targeted. Key Findings Aged hippocampi carried more FTL1: Transcriptomic and mass-spectrometry analyses found neuronal FTL1 increased in the hippocampus of old …
SuperAgers Reveal Brain Biology of Preserved Memory TL;DR: Octogenarians who recall words like 50-year-olds carry a distinct brain profile: preserved cortical volume, a cingulate cortex thicker than younger adults, larger entorhinal neurons, fewer inflammatory microglia, and more von Economo neurons — the biology is real, not just motivational. Key Findings Age-80 memory matched 50-to-60-year-olds: SuperAgers …
Broken Blood Vessels May Drive Alzheimer’s Decline TL;DR: A new study reveals that impaired cerebrovascular function—the brain’s ability to regulate blood flow—correlates strongly with Alzheimer’s symptoms, offering a potential non-invasive way to detect early cognitive decline. Alzheimer’s disease has long been framed as a problem of toxic protein accumulation: amyloid plaques and tau tangles strangling …
The Death Complex Fueling Alzheimer’s (And How to Stop It) TL;DR: Researchers discovered a toxic interaction between two brain proteins—NMDAR and TRPM4—that drives neurodegeneration in Alzheimer’s disease, and a small molecule called FP802 that blocks this “death complex” and prevents cognitive decline in mice. Alzheimer’s disease devastates the brain through multiple pathways, but the exact …
Blood Test Detects Alzheimer’s with 83% Accuracy TL;DR: A new blood test using three misfolded plasma proteins can identify Alzheimer’s disease with 83.44% accuracy, outperforming conventional biomarkers and offering a non-invasive screening tool years before cognitive symptoms appear. The holy grail of Alzheimer’s research isn’t a cure—yet. It’s catching the disease before memory starts to …
Omega-3 supplements and Souvenaid® show potential in slowing cognitive decline in Alzheimer’s patients, though the evidence remains inconclusive. Highlights: Cognitive Decline Reduction: The CDR scale showed a significant reduction in cognitive decline progression with Omega-3 supplementation (SMD = −0.4127, 95% CI: [−0.5926; −0.2327]). Mixed Cognitive Outcomes: 58% of studies reported positive cognitive effects from Omega-3 …
ACOT7 shows promise as a non-invasive serum biomarker for Alzheimer’s disease (AD) with high diagnostic accuracy. Highlights: Increased Expression: ACOT7 levels were significantly elevated in AD patients and animal models compared to controls. Correlation with Cognitive Decline: A strong negative correlation was observed between serum ACOT7 levels and MMSE scores (r = -0.85; p < …
Elevated blood urea nitrogen and creatinine ratio (BUNCr) is associated with decreased cognitive function and increased depressive symptoms, with depressive symptoms mediating part of the relationship between BUNCr and cognitive decline. Highlights: BUNCr has a negative association with cognitive function, with higher BUNCr levels linked to lower cognitive performance. BUNCr is positively associated with depressive …
Women experiencing midlife stress-related exhaustion have a higher risk of developing dementia at a younger age and exhibit long-term cognitive impairments. Highlights: Higher Dementia Risk: Women with midlife stress-related exhaustion had a nearly threefold increased risk of developing dementia before age 75. Earlier Onset: The average age of dementia onset was younger for women with …
